Regulatory Science Ireland: bridging the information gap on biosimilar medicines

Files in this item

Icon
Name: 2544.pdf
Size: 226.1Kb
Format: PDF
Description: Accepted Version
View/Open

Regulatory Science Ireland: bridging the information gap on biosimilar medicines

O'Callaghan, Joan; Barry, Sean; Moore, Una; Bermingham, Margaret; Morris, J. Michael; Hallinan, Frank; Griffin, Brendan T.
Date: 2016-10-31
Copyright: © 2016 Pro Pharma Communications International. The original publication is available at www.gabi-journal.net
Related: http://gabi-journal.net/
Citation: O'Callaghan, J., Barry, S., Moore, U., Bermingham, M., Morris, J. M., Hallinan, F. and Griffin, B. T. (2016) 'Regulatory Science Ireland: Bridging the information gap on biosimilar medicines', GaBI Journal, 5(4), pp. 168-170. doi:10.5639/gabij.2016.0504.043
Published Version: 10.5639/gabij.2016.0504.043

Abstract:

Regulatory Science Ireland (RSI) is a voluntary network of interested parties from academia, the Health Products Regulatory Authority (HPRA), pharmaceutical and medical device industries and government agencies. RSI is conducting a research project, the objective of which is to enhance understanding of biosimilar medicines amongst stakeholders and encourage best practice in the use of these medicines.

Show full item record

This item appears in the following Collection(s)

This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement